China Molecular Diagnostics Market & Volume Forecast, by Application [Oncology Testing, Infectious Disease Testing, and Genetic Disease Testing]

1.    Introduction

2.    Research Methodology
3.    Executive Summary

4.    Market Dynamics

4.1    Growth Driver
4.2    Challenges

5.    China Molecular Diagnostic Market & Test Volume

5.1    China Molecular Diagnostic Market
5.2    China Molecular Diagnostic Test Volume

6.    Market Share – China Molecular Diagnostic Share Analysis

6.1    Segments
6.2    Disease
6.3    Oncology Test
6.4    Genetic Test
6.5    Infectious Disease Test

7.    Volume Share – China Molecular Diagnostics

7.1    Segments
7.2    Disease
7.3    Oncology Test
7.4    Infectious Disease Test
7.5    Genetic Test

8.    Disease – China Molecular Diagnostic Test Volume

8.1    Oncology Test Volume

8.1.1    Breast Cancer Test Volume
8.1.2    Colorectal Cancer Test Volume
8.1.3    Prostate Cancer Test Volume

8.2    Infectious Disease Test Volume

8.2.1    Virology Test Volume
8.2.2    HPV Test Volume

8.3    Genetic Test Volume

8.3.1    Blood Screening Test Volume
8.3.2    HLA Test Volume

9.    Disease – China Molecular Diagnostic Market

9.1    Oncology Testing Market

9.1.1    Breast Cancer Testing Market
9.1.2    Colorectal Cancer Testing Market
9.1.3    Prostate Cancer Testing Market

9.2    Infectious Disease Testing Market

9.2.1    Virology Testing Market
9.2.2    HPV Testing Market

9.3    Genetic Testing Market

9.3.1    Blood Screening Market
9.3.2    HLA Testing Market

10.    China Healthcare Insurance Schemes

10.1    China Healthcare Insurance Schemes

10.1.1    New Rural Cooperative Medical Scheme (NRCMS)
10.1.2    Urban Employed Basic Medical Insurance (UEBMI)
10.1.3    Urban Resident Basic Medical Insurance (URBMI)
10.1.4    Private Health Insurance

11.    Profiles of Private Clinical Labs and Diagnostic Services Companies

11.1    Zhejiang Di’an Diagnostics Technology Co., Ltd.

11.1.1    Company Overview
11.1.2    Products and Services Offered by Di’an

11.2    ADICON Clinical Laboratories (Privately held)

11.2.1    Company Overview
11.2.2    Products and Services Offered by ADICON

11.3    Guangzhou Kingmed Diagnostics Center Co. Ltd.

11.3.1    Company Overview
11.3.2    Products and Services Offered by Kingmed

11.4    Kindstar Global (Privately held)    

11.4.1    Company Overview
11.4.2    Products and Services Offered by Kindstar

11.5    BGI–Shenzhen

11.5.1    Company Overview
11.5.2    BGI’s Innovative Approach

11.6    OriGene Technologies

11.6.1    Company Overview
11.6.2    Products and Services Offered by OriGene

List of Figures:

Figure 3‑1:        China – Healthcare Spending (Billion US$), 2011 & 2020
Figure 4‑1:        China – Molecular Diagnostic Market (Million US$), 2015 – 2019
Figure 4‑2:        China – Forecast for Molecular Diagnostic Market (Million US$), 2020 – 2026
Figure 4‑3:         China – Molecular Diagnostic Test Volume (Million), 2015 – 2019
Figure 4‑4:         China – Forecast for Molecular Diagnostic Test Volume (Million), 2020 – 2026
Figure 5‑1:         China – Molecular Diagnostic Market Share (Percent), 2015 – 2019
Figure 5‑2:        China – Forecast for Molecular Diagnostic Market Share (Percent), 2020 – 2026
Figure 5‑3:        China – Molecular Oncology Test Market Share (Percent), 2015 – 2019
Figure 5‑4:        China – Forecast for Molecular Oncology Test Market Share (Percent), 2020 – 2026
Figure 6‑1:        China – Molecular Diagnostic Test Volume Share (Percent), 2015 – 2019
Figure 6‑2:        China – Forecast for Molecular Diagnostic Test Volume Share (Percent), 2020– 2026
Figure 6‑3:        China – Molecular Oncology Test Volume Share (Percent), 2015 – 2019
Figure 6‑4:        China – Forecast for Molecular Oncology Test Volume Share (Percent), 2020 – 2026
Figure 7‑1:        Rural China – Cancer Screening Sites by Cancer Type (Number), 2013
Figure 7‑2:        China – Oncology Test Volume (Million), 2015 – 2019
Figure 7‑3:        China – Forecast for Oncology Test Volume (Million), 2020 – 2026
Figure 7‑4:        China – Breast Cancer Molecular Test Volume (Million), 2015 – 2019
Figure 7‑5:        China – Forecast for Breast Cancer Molecular Test Volume (Million), 2020 – 2026
Figure 7‑6:        China – Colorectal Cancer Test Volume (Million), 2015 – 2019
Figure 7‑7:        China – Forecast for Colorectal Cancer Test Volume (Million), 2020 – 2026
Figure 7‑8:        China – Prostate Cancer Test Volume (Million), 2015 – 2019
Figure 7‑9:        China – Forecast for Prostate Cancer Test Volume (Million), 2020 – 2026
Figure 7‑10:      China – Infectious Disease Test Volume (Million), 2015 – 2019
Figure 7‑11:      China – Forecast for Infectious Disease Test Volume (Million), 2020 – 2026
Figure 7‑12:      China – Virology Test Volume (Million), 2015 – 2019
Figure 7‑13:      China – Forecast for Virology Test Volume (Million), 2020 – 2026
Figure 7‑14:      China – HPV Test Volume (Thousand), 2015 – 2019
Figure 7‑15:      China – Forecast for HPV Test Volume (Thousand), 2020 – 2026
Figure 7‑16:      China – Genetic Test Volume (Million), 2015 – 2019
Figure 7‑17:      China – Forecast for Genetic Test Volume (Million), 2020 – 2026
Figure 7‑18:      China – Blood Screening Test Volume (Million), 2015 – 2019
Figure 7‑19:      China – Forecast for Blood Screening Test Volume (Million), 2020 – 2026
Figure 7‑20:      China – HLA Test Volume (Thousand), 2015 – 2019
Figure 7‑21:      China – Forecast for HLA Test Volume (Thousand), 2020 – 2026
Figure 8‑1:        China – Oncology Testing Market (Million US$), 2015 – 2019
Figure 8‑2:        China – Forecast for Oncology Testing Market (Million US$), 2020 – 2026
Figure 8‑3:        China – Breast Cancer Testing Market (Million US$), 2015 – 2019
Figure 8‑4:        China – Forecast for Breast Cancer Testing Market (Million US$), 2020 – 2026
Figure 8‑5:        China – Colorectal Cancer Testing Market (Million US$), 2015 – 2019
Figure 8‑6:        China – Forecast for Colorectal Cancer Testing Market (Million US$), 2020 – 2026
Figure 8‑7:        China – Prostate Cancer Testing Market (Million US$), 2015 – 2019
Figure 8‑8:        China – Forecast for Prostate Cancer Testing Market (Million US$), 2020 – 2026
Figure 8‑9:        China – Infectious Disease Testing Market (Million US$), 2015 – 2019
Figure 8‑10:     China – Forecast for Infectious Disease Testing Market (Million US$), 2020 – 2026
Figure 8‑11:     China – Virology Testing Market (Million US$), 2015 – 2019
Figure 8‑12:    China – Forecast for Virology Testing Market (Million US$), 2020 – 2026
Figure 8‑13:    China – HPV Testing Market (Million US$), 2015 – 2019
Figure 8‑14:    China – Forecast for HPV Testing Market (Million US$), 2020 – 2026
Figure 8‑15:    China – Genetic Testing Market (Million US$), 2015 – 2019
Figure 8‑16:    China – Forecast for Genetic Testing Market (Million US$), 2020– 2026
Figure 8‑17:    China – Blood Screening Market (Million US$), 2015 – 2019
Figure 8‑18:    China – Forecast for Blood Screening Market (Million US$), 2020 – 2026
Figure 8‑19:    China – HLA Testing Market (Million US$), 2015 – 2019
Figure 8‑20:    China – Forecast for HLA Testing Market (Million US$), 2020 – 2026
Figure 10–10‑1:    Kindstar – Collaboration with Hospitals in China (Number), 2006 – 2012

List of Tables:

Table 3‑1:        China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Table 3‑2:         Number of hospital beds for every 1,000 people
Table 5‑1:         China – Molecular Diagnostic Application Market Share (Percent), 2015 – 2019
Table 5‑2:         China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2020 – 2026
Table 5‑3:         China – Molecular Genetic Test Market Share (Percent), 2015 – 2019
Table 5‑4:         China – Forecast for Molecular Genetic Test Market Share (Percent), 2020 – 2026
Table 5‑5:         China – Molecular Infectious Disease Test Market Share (Percent), 2015 – 2019
Table 5‑6:         China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2020 – 2026
Table 6‑1:         China – Molecular Diagnostic Test Volume Application Share (Percent), 2015 – 2019
Table 6‑2:         China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2020 – 2026
Table 6‑3:         China – Molecular Infectious Disease Test Volume Share (Percent), 2015 – 2019
Table 6‑4:         China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2020 – 2026
Table 6‑5:         China – Molecular Genetic Test Volume Share (Percent), 2015 – 2019
Table 6‑6:         China – Forecast for Molecular Genetic Test Volume Share (Percent), 2020 – 2026